Hopen Life Science Ventures

Venture Capital Firm

Hopen Life Science Ventures
Contact

Hopen Life Science Ventures

Hopen Life Science Ventures

Name
Hidden

Hopen Life Science Ventures invests in exceptional early to mid-stage healthcare and life science opportunities. The firm’s investment strategy focuses on Midwest companies with innovative solutions that deliver significantly better outcomes and at lower total system costs. Hopen leverages its rich life science talent and resources, and investor syndicates to provide the financial and human capital necessary for building value.

Contact

Team

  • Nathan Fredrickson
    Associate, Hopen Life Science Ventures
  • Michael Fulton
    Managing Director, Hopen Life Science Ventures
  • Mark Olesnavage
    Managing Director, Hopen Life Science Ventures
  • Mike Jandernoa
    Managing General Partner, Hopen Life Science Ventures

Stages of Investment

  • Growth/Expansion

Sectors of Investment

  • n/a

IT Subsectors

Life Science Subsectors

  • Biotechnology
  • Devices
  • Diagnostics
  • Healthcare Services
  • Other
  • Pharmaceuticals

Details

  • Assets Under Management $70,900,000

The most timely & relevant email you will get about Michigan’s investment & entrepreneurial ecosystem.

From public policy to the new ideas and breakthrough investment opportunities, MVCA will keep your finger on the pulse of must know information in the industry.

Newsletter

This field is for validation purposes and should be left unchanged.